{"id": "1344810573805080578", "creation": 1609462800.0, "user_id": "1211892441529241601", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 2, "reply_count": 0, "like_count": 5, "quote_count": 3}}, "text": "A Chinese inactivated #vaccine shows 79.34% efficacy against #COVID19, according to interim results of phase-3 clinical trials unveiled by developer on Dec. 30. It's developed by Beijing Biological Products Institute Co., Ltd. under the #CNBG, which is affiliated with #Sinopharm. https://t.co/tPpHFFWMAt", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19", "#CNBG", "#SINOPHARM"]}